Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01152268 · ClinicalTrials.gov registry record

Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool

A clinical trial of Cancer, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
282
Enrollment target
9
Study locations

NCT01152268: Completed study of Cancer, sponsored by St. Jude Children's Research Hospital.

NCT01152268 is a study of Cancer that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 282 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (92% lower). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01152268, a study of Cancer, has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
282 participants
Enrollment target
9
Study locations

Study Summary

Despite the known adverse effects of specific cancer treatments on fertility, only 18-26% of at-risk adolescents and young men cryopreserve sperm prior to cancer treatment in the US: These already less than optimal rates of sperm banking are even lower among adolescents who have increased anxiety at cancer diagnosis, are lower in age and socioeconomic status, of Evangelical religious orientation, or are diagnosed with leukemia/lymphoma: It is not clear why sperm banking is underutilized, particularly in light of the high priority that survivors of childhood cancer place on fertility and the high psychological distress associated with fertility loss. Studies addressing sperm banking among adults with cancer suggest that factors such as poor physician communication and the resulting lack of fertility-risk knowledge by patients contributes to the low frequency of sperm cryopreservation. No well-designed studies have examined risk factors associated with failure to bank sperm among adolescents with cancer, a developmentally distinct population ripe for intervention. This study plans to enroll 206 adolescent males and 412 parents/guardians.

Primary Outcome

Investigate factors predictive of banking sperm/not banking sperm among at-risk adolescents newly diagnosed with cancer. Psychological, health belief, demographic, developmental, parental/guardian, provider, and medical factors will be tested in models of sperm banking outcome.

Conditions Studied

Study Locations (9)

California

  • City of Hope - Duarte
  • Mattel Children's Hospital - Los Angeles

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Massachusetts

  • Dana-Farber Cancer Institute/Children's Hospital Boston - Boston

Michigan

  • The University of Michigan - Ann Arbor

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Texas

  • Cook Children's Medical Center - Fort Worth

Utah

  • Primary Children's Medical Center - Salt Lake City

Ontario

  • The Hospital for Sick Children - Toronto

Trial Details

FieldValue
Enrollment Target 282 participants
Start Date 2010-07
Est. Completion 2014-06

What the finished NCT01152268 record still lists

NCT01152268 is an observational study that tracks outcomes without assigning an intervention. The registered 282 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT01152268 lists 9 locations in 8 states (California, Georgia, Massachusetts).

Frequently Asked Questions

What is clinical trial NCT01152268 about?

NCT01152268 is a clinical study titled "Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool". Despite the known adverse effects of specific cancer treatments on fertility, only 18-26% of at-risk adolescents and young men cryopreserve sperm prior to cancer treatment in the US: These already less than optimal rates of sperm banking are even lower among adolescents who have increased anxiety at...

What is the current status of trial NCT01152268?

This trial is currently completed. The enrollment target is 282 participants. The study started on 2010-07. Estimated completion is 2014-06.

What conditions does trial NCT01152268 study?

This clinical trial studies the following conditions: Cancer.

Who is sponsoring clinical trial NCT01152268?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01152268 being conducted?

This trial has 9 study locations across California, Georgia, Massachusetts, Michigan, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01152268's enrollment target sits among peer trials

282 191st of 615 higher than 425 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02860364 · 282 participants · NA

    Comparing Hypothermic Temperatures During Hemiarch Surgery

  • NCT04867395 · 282 participants · NA

    A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

  • NCT05101070 · 282 participants · Phase 1

    S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

  • NCT06276491 · 282 participants · Phase 1

    Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01152268, the US trial registry maintained by the National Library of Medicine. NCT01152268 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.